Journalism begins where hype ends

,,

AI is not about replacing humans. It's about amplifying human potential."

— Fei-Fei Li

AI Meets Big Pharma: Isomorphic Labs Raises $2.1 Billion for AI Drug Discovery

Isomorphic Labs, founded in 2021 by DeepMind chief Demis Hassabis, has raised $2.1 billion in Series B funding to scale its AI-driven drug discovery platform.

Demis Hassabis’s AI drug discovery startup Isomorphic Labs has raised $2.1 billion in a Thrive Capital-led Series B, joined by Alphabet, GV, MGX, Temasek, CapitalG and the UK Sovereign AI Fund.

“We are just 5-8 years away from AGI”: Deepmind’s Hassabis at AI Impact Summit

Demis Hassabis, CEO of Google Deepmind, claimed that humans are just 5-8 years away from artificial general intelligence (AGI), at India AI Impact Summit 2026, New Delhi.